Clinical Trial

Neuropsychological Assessment of Children and Adolescents With Turner Syndrome

Study acronym: ENEAST
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated December 5, 2025 completion). Its status may not reflect the trial's current state.
Summary
Turner syndrome (TS) is a rare chromosomal disorder characterized by partial or complete loss of one of the X chromosomes that affects about one in every 2000 female babies born. These young patients described difficulties making friends, understanding others' emotions and intentions, and controlling their own emotions. Difficulties in these domains could led to social withdrawal, to reduced social skills and could have a significant impact on self esteem and mental health as well as on long-term academic and social functioning in affected individuals. The purpose of this project is to identify functional and dysfunctional cognitive and socio-cognitive abilities in these young patients which could account social difficulties described by some of them and their family. To this end, 35 girls with TS and 35 girls with isolated growth hormone deficiency and normal cerebral MRI will be recruited. Subjects will be 7 to 16 years and 11 months of age. Socio-cognitive and cognitive functions will be assessed with neuropsychological and experimental tasks. Questionnaires completed by patient, parents or teacher, will evaluate social and behavioral functioning.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2019-01-17.
Status change: Not Yet Recruiting → Recruiting 2024-12-26
Trial Details
NCT Number NCT03812913
Lead Sponsor University Hospital, Angers
Conditions Turner Syndrome, Isolated Growth Hormone Deficiency, Cognitive Functions, Social Cognition, Pediatrics
Enrollment 70 participants
Start Date 2019-09-05
Primary Completion 2025-12-05 (estimated)
Study Completion 2025-12-05 (estimated)
Updated on ClinicalTrials.gov 2024-12-30